Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Multiple Sclerosis and Related Disorders|May 29, 2024
The multidimensional assessment of body representation and interoception in multiple sclerosisSimona Raimo, Gina Ferrazzano, Antonella Di Vita, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapyRoberta Lanzillo, Giuseppe Orefice, Mario Quarantelli, et al.
Plos One|September 20, 2019
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare deliveryMarcello Moccia, Andrea Tajani, Rosa Acampora, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2016
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation testsFrancesco Saccà, Teresa Costabile, Antonio Carotenuto, et al.
Neuropsychology|December 11, 2025
From the body and through the body: A multidimensional assessment of functional body representations, interoceptive dimensions, and quality of life in multiple sclerosisSimona Raimo, Gina Ferrazzano, Antonella Di Vita, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2023
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker studyGiancarlo Comi, Letizia Leocani, Luigi Ferini-Strambi, et al.
Multiple Sclerosis and Related Disorders|April 22, 2023
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)Teresa Costabile, Elisabetta Signoriello, Francesca Lauro, et al.
Multiple Sclerosis and Related Disorders|January 23, 2026
Theory of mind in multiple sclerosis: Three-month follow-up effects after double-blind tDCS and video-training, a pilot studyLidia Ammendola, Daniela Malangone, Maria Cropano, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
International Journal of Environmental Research and Public Health|August 7, 2021
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with OcrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Pageof 12